Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovotech ( (TSE:IOT) ) just unveiled an update.
Innovotech Inc. reported record revenues of $1,267,692 for the third quarter of 2025, with a net income of $92,945, driven by increased demand for antimicrobial contract research, strong analytical services performance, and higher product sales. The company’s strategic investments and expansion efforts are reflected in its financial success, positioning it for continued growth in its industry.
More about Innovotech
Innovotech Inc. is a Canadian technology company operating in specialized laboratory services, biotechnology, and proprietary intellectual property. It manages several subsidiaries, including Innovotech Labs Corporation, which focuses on antimicrobial testing and silver solutions, and Keystone Labs Inc., serving the Canadian pharmaceutical and industrial markets. Innovotech also holds a majority stake in NouLifeSciences Inc., which develops antioxidant molecules for cosmetics and medical applications.
Average Trading Volume: 28,783
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$11.81M
For an in-depth examination of IOT stock, go to TipRanks’ Overview page.